AXIM Biotechnologies, Inc.
AXIM
$0.003
$0.000.00%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 56.09% | 19.22% | -29.10% | 47.31% | 35.70% |
| Total Depreciation and Amortization | 0.61% | 0.49% | 0.28% | -60.47% | -74.48% |
| Total Amortization of Deferred Charges | -13.80% | -40.34% | -43.62% | -53.98% | -53.35% |
| Total Other Non-Cash Items | -76.29% | -6.55% | 117.17% | -55.75% | -37.29% |
| Change in Net Operating Assets | -0.26% | -113.41% | 24.33% | 143.35% | 1,059.24% |
| Cash from Operations | 46.64% | -31.90% | 49.59% | 45.85% | 47.96% |
| Capital Expenditure | -3.70% | 67.82% | -- | 100.00% | 89.81% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -3.70% | 67.82% | -- | 100.00% | 92.60% |
| Total Debt Issued | -43.11% | -- | -49.06% | -75.02% | -77.24% |
| Total Debt Repaid | 100.00% | 100.00% | 98.11% | 95.75% | 92.19% |
| Issuance of Common Stock | 6.76% | 0.76% | -71.79% | -53.98% | -41.02% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -54.00% | 76.10% | -30.81% | -48.45% | -44.65% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -382.41% | 112.19% | 126.92% | 19.53% | 123.65% |
